Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Vertex: Growth At An Acceptable Valuation
04:44am, Tuesday, 25'th Jan 2022
AFT is a closed end fund focusing on leveraged loans. The vehicle provides for a natural inflation hedge given the floating rate nature of the underlying loans.
Should You Buy Vertex Pharmaceuticals (VRTX) Ahead of Earnings?
12:20pm, Monday, 24'th Jan 2022
Vertex Pharmaceuticals (VRTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
PTC Gearing Up for Q1 Earnings: What is in the Offing?
09:17am, Monday, 24'th Jan 2022
PTC is likely to have reported higher year-over-year revenues in first-quarter fiscal 2022, driven by significant growth across all product segments and regions.
3 Unstoppable Biotech Stocks to Buy Right Now
06:04am, Monday, 24'th Jan 2022
All of them have tremendous growth prospects.
6 Must-Buy Large-Cap Stocks Ahead of Q4 Earnings Next Week
08:30am, Friday, 21'st Jan 2022
Six large-cap companies will report earnings next week. These are: TSLA, URI, FCX, VRTX, STLD and BRO.
Vertex upgraded to outperform at BMO on bullish outlook for rare kidney disease candidate
05:40pm, Thursday, 20'th Jan 2022 Seeking Alpha
BMO has upgraded shares of Vertex Pharmaceuticals based on recent promising data for VX-147, its candidate for the rare kidney condition focal segmental glomerulosclerosis.
Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?
01:50pm, Thursday, 20'th Jan 2022
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Stocks With Impressive Interest Coverage Ratio to Invest In
01:04pm, Thursday, 20'th Jan 2022
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as ArcBest (ARCB), Advanced Micro Devices (AMD), AGCO Corporation (AGC
4 Reasons to Buy Vertex Pharmaceuticals (VRTX) Stock in 2022
12:16pm, Thursday, 20'th Jan 2022
New reimbursement agreements in ex-U.S. markets and label expansions to younger age groups are driving sales of Vertex's (VRTX) triple therapy cystic fibrosis drug, Trikafta/Kaftrio higher.
Will 2022 Be a Better Year for Biotech Than 2021? 3 Big Picks
12:19pm, Wednesday, 19'th Jan 2022
Regeneron (REGN), Vertex Pharmaceuticals (VRTX) and BioNTech (BNTX) are three large biotech stocks that are worth betting on in the current scenario.
Vertex to Announce Fourth Quarter 2021 Financial Results on January 26
04:05pm, Tuesday, 18'th Jan 2022
BOSTON ----(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2021 financial results on Wednesday, January 26, 2022 after the financial ma
Buy These Stocks If You Want 126% to 206% Returns, Says Wall Street
11:00am, Tuesday, 18'th Jan 2022
These two biotechs have potential catalysts to look forward to in 2022.
5 Top Biotech Stocks To Watch In January 2022
02:30pm, Sunday, 16'th Jan 2022
Could these biotech stocks be poised for gains in 2022?
4 Biotech Acquisitions We'd Like to See in 2022
06:10am, Friday, 14'th Jan 2022
These potential corporate combinations would make a lot of sense.
